The Chemokine Receptor CCR5 Plays a Key Role in the Early Memory CD8+ T Cell Response to Respiratory Virus Infections  by Kohlmeier, Jacob E. et al.
Immunity
ArticleThe Chemokine Receptor CCR5 Plays a Key Role
in the Early Memory CD8+ T Cell Response
to Respiratory Virus Infections
Jacob E. Kohlmeier,1 Shannon C. Miller,1 Joanna Smith,1 Bao Lu,2 Craig Gerard,2 Tres Cookenham,1
Alan D. Roberts,1 and David L. Woodland1,*
1Trudeau Institute, Saranac Lake, NY 12983, USA
2Pulmonary Division, Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA
*Correspondence: dwoodland@trudeauinstitute.org
DOI 10.1016/j.immuni.2008.05.011SUMMARY
Innate recognition of invading pathogens in periph-
eral tissues results in the recruitment of circulating
memory CD8+ T cells to sites of localized inflamma-
tion during the early phase of a recall response. How-
ever, the mechanisms that control the rapid recruit-
ment of these cells to peripheral sites are poorly
understood, particularly in relation to influenza and
parainfluenza infections of the respiratory tract. In
this study, we demonstrate a crucial role for C-C che-
mokine receptor 5 (CCR5) in the accelerated recruit-
ment of memory CD8+ T cells to the lung airways
during virus challenge. Most importantly, CCR5 defi-
ciency resulted in decreased recruitment of memory
T cells expressing key effector molecules and im-
paired control of virus replication during the initial
stages of a secondary response. These data high-
light the critical importance of early memory T cell
recruitment for the efficacy of cellular immunity in
the lung.
INTRODUCTION
After the resolution of an acute virus infection, pathogen-specific
memory T cells capable of persisting for many years are estab-
lished in both lymphoid and peripheral tissues. During a second-
ary-pathogen encounter, recall responses are initiated by the
presentation of antigen to quiescent memory T cells within lym-
phoid tissues, resulting in the generation of large numbers of
secondary effector T cells, which subsequently traffic to sites
of inflammation (Dutton et al., 1998; Zammit et al., 2005; Zimmer-
mann et al., 1999). In the case of influenza and parainfluenza
virus infections of the respiratory tract, memory CD8+ T cells
have been shown to mediate accelerated virus clearance and
improved survival upon secondary challenge. However, there
is increasing evidence that early events, prior to the generation
of secondary effector T cells, play a key role in mediating en-
hanced cellular immunity to respiratory infections (Lefrancois
and Puddington, 2006). First, it has been demonstrated that vi-
rus-specific memory T cells conferred increased protection by
limiting virus replication during the initial days of a secondarychallenge (Liang et al., 1994). Second, several reports have
shown a dramatic increase in the number of antigen-specific
memory CD8+ T cells in the lung prior to the appearance of sec-
ondary effector T cells (Chen et al., 2001; Ely et al., 2003; Mar-
shall et al., 2001; Topham et al., 2001). Together, these findings
have led to a revised model of the dynamics of recall responses
in the lung: an early phase mediated by the rapid recruitment of
circulating memory T cells, and a late phase mediated by sec-
ondary effector T cells (Hikono et al., 2006; Woodland and Ran-
dall, 2004). Importantly, it is the combined effects of this early
phase of memory T cell recruitment and the later appearance
of secondary effector T cells at the site of infection that together
result in the overall enhancement in the rapidity and magnitude of
the recall response.
Although the precise mechanisms controlling memory T cell
recruitment during respiratory infections have not yet been
described, studies utilizing BrdU-labeling and epitope-deficient
viruses have established that the early influx of memory CD8+
T cells is due to the inflammation-dependent recruitment of non-
dividing cells from the circulation to the lung airways (Ely et al.,
2003; Turner et al., 2001). Notably, only the effector memory
(CD62LloCCR7) CD8+ T cell subset appears to be recruited to
the airways during the early phase of a recall response. This find-
ing has considerable implications for the efficacy of the early
phase of the recall response toward specific pathogens as a re-
sult of the gradual conversion from an effector memory (Tem) to
a central memory (Tcm) cell phenotype within the systemic
memory T cell population (Jabbari and Harty, 2006; Masopust
et al., 2001; Roberts and Woodland, 2004; Wherry et al., 2003).
Thus, because the antigen specificity of the recruited Tem pop-
ulation is biased toward recently encountered pathogens, the
number of antigen-specific memory T cells specific for a particu-
lar pathogen recruited during the early phase of a recall response
wanes over time after clearance of the initial infection (Flynn
et al., 1998; Hogan et al., 2001a). These data highlight the differ-
ent requirements for the propagation of the early and late phases
of a recall response. Whereas the late phase is dependent on the
antigen-dependent proliferation of Tcm cells in lymphoid tissue
in order to generate secondary effector T cells, the early phase
is mediated by the rapid, antigen-independent recruitment of
nonproliferating Tem cells to the inflamed lung.
A key unanswered question that arises from these findings is
how memory CD8+ T cells are recruited to the airways during
the early stage of a recall response. Currently, much of ourImmunity 29, 101–113, July 18, 2008 ª2008 Elsevier Inc. 101
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Memory CD8+ T Cell Recruitment to the Lung Airwaysunderstanding regarding the mechanisms of T cell trafficking to
the lung is derived from the examination of immune responses
to primary virus infections or chronic inflammatory conditions
(Cerwenka et al., 1999; Kohlmeier and Woodland, 2006; Medoff
et al., 2005). In the case of primary influenza virus infection, anal-
ysis of chemokine mRNA expression showed increased expres-
sion of CCL2, CCL3, CCL4, CCL5, and CXCL10, but an analysis
of receptor mRNA expression indicated that only CXCR3 (the
receptor for CXCL10) was increased in the lungs at the peak of
the primary immune response (Wareing et al., 2004). However,
in this study, primary immune responses to influenza virus infec-
tion were largely unimpaired in CXCR3-deficient mice, whereas
another study identified an important role for CCR5 in the clinical
outcome of influenza infection (Dawson et al., 2000). One intrigu-
ing report has identified a crucial and nonredundant role for
CCR5 in the trafficking of effector CD8+ T cells to the nonin-
flamed lung as a result of the constitutive expression of CCL5
in lung tissue (Galkina et al., 2005). However, it is unclear whether
CCR5-mediated trafficking is of equal importance for the locali-
zation of memory CD8+ T cells to the lung during recall re-
sponses, and whether the same mechanisms that govern re-
cruitment to the lung parenchyma are also important for
recruitment to the lung airways. Furthermore, although several
reports have analyzed the expression of chemokine receptors
on antigen-specific memory CD8+ T cells generated after respi-
ratory infections, it is unclear which chemokine receptors may
be important for the trafficking of these cells to sites of inflamma-
tion during a recall response (Hoji and Rinaldo, 2005; Roberts
et al., 2005).
The lung airways provide an excellent model for the investiga-
tion of the mechanisms that govern the accelerated recruitment
of memory CD8+ T cells to inflammatory sites during the early
stages of a recall response. First, as a site of privileged entry, lo-
calized inflammation is required for the trafficking of substantial
numbers of memory T cells from the circulation to the airways.
Second, memory T cells localized to the lung airways have the
unique property of downregulating LFA-1. LFA-1 is an adhesion
molecule, comprising the CD11a and CD18 subunits, that is
highly expressed on systemic and most peripheral T cells and
is important for lymphocyte extravisation and migration (Smith
et al., 2007). Downregulation of LFA-1 occurs upon exposure
to the airway environment, so that by 40 hr after entry from the
circulation, memory T cells have shifted from a CD11ahi to
CD11alo phenotype (Ely et al., 2006). The consistent rate of
change in LFA-1 expression during both steady-state and in-
flammatory conditions, and the uniqueness of this phenomenon
to the lung airways, makes it possible to differentiate between
recently recruited (CD11ahi) and resident (CD11alo) T cells within
the airways (Kohlmeier et al., 2007). Third, because antigen-spe-
cific memory T cells transferred directly into the airways have
been shown to limit virus replication during secondary challenge,
the impact of limiting early memory CD8+ T cell recruitment
in vivo during a recall response can be directly assessed by mea-
suring virus titers (Hogan et al., 2001b).
In the present study, we investigated the role of specific che-
mokine receptors in the accelerated recruitment of virus-specific
memory CD8+ T cells to the lung airways during the early phase
of a recall response and the impact of chemokine-receptor defi-
ciency on the efficacy of the cellular recall response. The data102 Immunity 29, 101–113, July 18, 2008 ª2008 Elsevier Inc.show that, although both CXCR3- and CCR5-binding chemo-
kines were rapidly induced after secondary challenge and
CXCR3 was highly expressed on virus-specific cells, the accel-
erated recruitment of memory CD8+ T cells to the lung airways
was entirely dependent on CCR5 expression by memory CD8+
T cells. Furthermore, the surface expression of CCR5 was rapidly
induced on memory CD8+ T cells after virus challenge, enabling
these cells to migrate to CCR5 ligands. Finally, we demonstrate
that accelerated recruitment is required for the antiviral effector
functions of memory CD8+ T cells in the airways and that defec-
tive recruitment in CCR5-deficient mice resulted in impaired
control of virus replication during a secondary challenge prior
to the generation of secondary effector T cells. Overall, these
data identify a crucial and nonredundant role for CCR5 in accel-
erated memory T cell recruitment during virus infection in the
lung and reveal the importance of this early-phase recruitment
for the efficacy of the recall response.
RESULTS
CXCR3 and CCR5 Chemokines Are Rapidly Expressed
after Respiratory Virus Challenge
Recent studies have demonstrated that respiratory virus infec-
tions elicit the recruitment of nonproliferating memory CD8+ T
cells to the lung airways in an antigen-independent fashion
during the first few days of infection (Ely et al., 2003). This recruit-
ment results in a substantial increase in the numbers of patho-
gen-specific memory T cells at the site of infection prior to the ar-
rival of secondary effector T cells. However, the specific signals
that direct this early phase of recruitment have not been identi-
fied. To begin to address this issue, we needed to isolate the
early inflammation-driven memory T cell phase of the recall re-
sponse from the later antigen-driven secondary effector phase.
Therefore, we employed a model where Sendai-immune mice
were challenged with an unrelated influenza virus, in order to in-
duce localized lung inflammation (and memory T cell recruit-
ment) in the absence of cognate antigen.
As previously described, recruitment of Sendai-specific mem-
ory CD8+ T cells to the lung airways was observed beginning 2
days after virus challenge (Figure 1A). This early recruitment
was visualized by an increased frequency of CD11ahi Sendai-
specific memory CD8+ T cells within the airways, because it
has been well documented that only memory T cells recently re-
cruited to the airways express high levels of CD11a (Ely et al.,
2006; Kohlmeier et al., 2007). To investigate the signals driving
the early phase of recruitment, we measured the expression of
numerous cytokines and chemokines associated with inflamma-
tory responses and T cell recruitment in whole lung tissue by
real-time PCR after virus challenge. Within 2 days of virus chal-
lenge, there was an increase in the expression of mRNA for nu-
merous proinflammatory mediators such as IFN-g, TNF-a, IL-6,
CCL2, and CXCL2 (Figure S1, available online). In addition, we
observed a dramatic increase in the expression of mRNA for
chemokines associated with the receptors CCR5 (CCL3,
CCL4, and CCL5) and CXCR3 (CXCL9 and CXCL10)
(Figure 1B). Notably, the increased expression of these chemo-
kine mRNAs on day 2 after challenge also coincided with the
onset of accelerated memory T cell recruitment. To confirm
that increased mRNA expression was associated with protein
Immunity
Memory CD8+ T Cell Recruitment to the Lung AirwaysFigure 1. Memory CD8+ T Cell Recruitment to the Lung Airways Coincides with Increased Expression of CCR5- and CXCR3-Binding Chemo-
kines
C57BL/6 mice were infected intranasally (i.n.) with 250 EID50 Sendai virus and allowed to rest for 45 days.
(A) Lung airway cells were harvested from Sendai-immune mice prior to (control) or on days 1–5 after challenge with 33 104 EID50 influenza x31 virus. The data
show staining of CD11a and Sendai NP324-332K
b tetramer gated on CD8+CD44hi cells. The data are representative of five independent experiments.
(B) RNA was extracted from whole lung tissue of mice after influenza x31 challenge, and the expression of chemokine genes was measured by real-time RT-PCR.
The data are shown as the n-fold induction (mean ± SD) of the indicated genes on days 1–5 after infection relative to unchallenged mice. The data are represen-
tative of three independent experiments.
(C) BAL fluid was harvested from Sendai-immune mice prior to (control) or on days 1–5 after influenza x31 challenge, and chemokine protein levels were measured
by luminex. Each symbol represents the value from an individual mouse, and the data are representative of two independent experiments.production, we also measured chemokine protein in the lung air-
ways by multiplex ELISA assays. As shown in Figure 1C, CXCR3
and CCR5 chemokines were dramatically upregulated in the lung
airways, confirming our mRNA data. Thus, the onset of elevated
expression of several chemokines known to promote the migra-
tion of T cells to inflammatory sites correlated with the acceler-
ated early recruitment of memory CD8+ T cells to the lung
airways, suggesting that CXCR3- and CCR5-binding chemo-
kines may be required for recruitment.
Resting Antigen-Specific Memory CD8+ T Cells Express
CXCR3, but Not CCR5, and Migrate in Response
to CXCR3 Chemokines
Because of the finding that both CXCR3- and CCR5-binding
chemokines were expressed in the lung during the early inflam-
matory response, we investigated whether antigen-specific
CD8+ T cells generated after acute respiratory virus infections
expressed functional CXCR3 and CCR5. After infection with
Sendai or influenza viruses, we measured the expression ofthese chemokine receptors on both effector and memory anti-
gen-specific CD8+ T cells. Surface expression of CXCR3 was
evident on Sendai-specific CD8+ T cells during both the acute
(day 10, Figure 2A) and memory phases (day 35, Figure 2B),
and nearly 75% of Sendai-specific memory CD8+ T cells at
day 35 after infection expressed CXCR3 regardless of their local-
ization to lymphoid or peripheral tissues. In contrast, although
a modest percentage of Sendai-specific CD8+ T cells expressed
CCR5 during the acute response, only approximately 2% of
Sendai-virus-specific memory CD8+ T cells expressed CCR5 in
all tissues examined. This pattern of chemokine-receptor ex-
pression was not pathogen dependent, because CXCR3 and
CCR5 expression was similar on antigen-specific CD8+ T cells
after both Sendai and influenza virus infections (Figure 2C). Im-
portantly, total memory T cells (defined as CD8+CD44hi) and an-
tigen-specific memory T cells migrated to CXCR3 ligands in vitro
(Figures 2D and 2E). Furthermore, as shown in Figure 2F, the
ability of Sendai NP324-332K
b+ memory T cells to migrate was de-
pendent on CXCR3 expression, because an analysis of memoryImmunity 29, 101–113, July 18, 2008 ª2008 Elsevier Inc. 103
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Memory CD8+ T Cell Recruitment to the Lung AirwaysFigure 3. CCR5 Expression on Memory
CD8+ T Cells Is Required for Accelerated
Recruitment to the Lung Airways after Virus
Challenge
(A) The expression of CD11a was examined on
CD8+ Sendai NP324-332K
b+ cells in the lung airways
from donor and host populations prior to or on
days 1–5 after influenza virus challenge. Repre-
sentative staining from an individual CXCR3-defi-
cient (upper panels) or CCR5-deficient (lower
panels) dual-transfer memory mouse is shown.
(B) The average frequency (mean ± SD) of recently
recruited (CD11ahi) Sendai NP324-332K
b+ cells from
each population is shown for CXCR3-deficient (left
graph) and CCR5-deficient (right graph) dual-
transfer memory mice during the course of an
influenza challenge. The data are representative
of three independent experiments.T cell subsets revealed that only those subsets that included
CXCR3+ cells (CD62L+, CD62L, and CD27+) were responsive
to CXCL9. In addition, neither total memory nor Sendai-specific
CD8+ T cells displayed any significant migratory ability to CCR5
ligands in vitro (data not shown). Taken together, these data
strongly suggested that CXCR3, and not CCR5, plays a primary
role in the early recruitment of memory CD8+ T cells from the cir-
culation to the lung airways during respiratory virus infection.
Expression of CCR5, but Not CXCR3, Is Required
for Accelerated Memory T Cell Recruitment
to the Lung Airways during Virus Challenge
The data thus far suggested that CXCR3, and not CCR5, was
required for early recruitment of memory T cells to the lung air-
ways during a recall response in vivo. To further investigate
this idea, we employed a dual adoptive-transfer system in which
the indicated chemokine receptors were absent on one popula-
tion of donor Sendai-specific memory CD8+ T cells (Figure S2A).
In brief, memory CD8+ T cells (CD44hi) were sorted from wild-
type or chemokine-receptor-deficient mice 45–60 days afterSendai infection. After sorting, the ratio of wild-type to chemo-
kine-receptor-deficient cells was adjusted so that the frequency
of Sendai NP324-332K
b+ cells was 1:1, and this mixture was in-
jected into congenic recipients that were then challenged with
Sendai virus the next day. Recipient mice were rested for 45
days to allow for the generation of three distinct populations of
memory T cells that could be segregated on the basis of the ex-
pression of congenic markers (Figure S2B). Using this model, we
were able to identify donor and host populations of memory
CD8+ T cells, and using CD11a as a marker for recent recruit-
ment to the lung airways, we were able to directly compare the
recruitment of wild-type and chemokine-receptor-deficient do-
nor cells in the same host.
As shown in Figure 3, we observed no difference in the fre-
quency of recently recruited (CD11ahi) Sendai-specific memory
CD8+ T cells after virus challenge when comparing wild-type
and CXCR3-deficient donor cells (Figure 3A, upper panel and
Figure 3B, left panel). Surprisingly, however, Sendai-specific
memory CD8+ T cells lacking CCR5 failed to show an increased
frequency of recently recruited (CD11ahi) cells after challengeFigure 2. Virus-Specific Memory CD8+ T Cells in Lymphoid and Peripheral Tissues Express CXCR3 and Migrate to CXCR3 Ligands In Vitro
(A and B) Naive C57BL/6 mice were infected with 250 EID50 Sendai virus or 1500 EID50 influenza PR8 virus. Mice were sacrificed on days 8, 10, 15, 21, and 35 after
infection, and the expression of CCR5 and CXCR3 on antigen-specific CD8+ T cells from the BAL, lung parenchyma, MLN, and spleen was measured by flow
cytometry. Representative staining of CCR5 and CXCR3 gated on Sendai NP324-332K
b+ cells is shown at day 10 (A) and day 35 (B) after infection.
(C) The frequency of Sendai NP324-332K
b+ (open circles) or Flu NP366-374D
b+ (closed squares) CD8+ T cells expressing CXCR3 (left column) or CCR5 (right column)
was measured at the indicated times after infection. The data are graphed as the mean ± SD of five mice for each time point and are representative of three
independent experiments.
(D) Splenocytes were harvested from C57BL/6 Sendai memory mice 45–60 days after infection. The migration of naive (open squares) or memory (filled squares) T
cells in response to increasing concentrations of CXCL9, CXCL10, and CXCL11 was determined with a standard in vitro chemotaxis assay.
(E) The ability of Sendai-specific CD8+ T cells to migrate to an optimal concentration of CXCL9 (5 mg/ml) was measured as described above. The plots on the left
show representative staining of the frequency of Sendai NP324-332K
b+ cells in the input or migrated population. The chemotactic index of naive, total memory
(CD8+ CD44hi), and Sendai-specific T cells is graphed on the right.
(F) The ability of Sendai-specific memory CD8+ T cell subsets to migrate to CXCL9 was examined on the basis of the expression of CD62L and CD27. Repre-
sentative staining of CXCR3, CD62L, and CD27 gated on Sendai NP324-332K
b+ cells are shown on the left. The chemotactic index of Sendai NP324-332K
b+ cells
in response to 5 mg/ml CXCL9 is shown for subsets based on the expression of CD62L (top graph) and CD27 (bottom graph). The data are representative of five
independent experiments.
The data for (D), (E), and (F) are graphed as the mean ± SD and are representative of five independent experiments.Immunity 29, 101–113, July 18, 2008 ª2008 Elsevier Inc. 105
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Memory CD8+ T Cell Recruitment to the Lung AirwaysFigure 4. Circulating Memory CD8+ T Cells Require CCR5 to Migrate to the Lung Airways, but Not Lung Parenchyma, during Virus Challenge
(A) Splenocytes from Sendai-immune CCR5-deficient or congenic (CD90.1+) wild-type were harvested 2 days after influenza challenge and mixed together so
that the frequency of Sendai NP324-332K
b+ cells was at a 1:1 ratio. Normalized splenocytes were injected i.v. into congenic mice (CD45.1+) that had also been
infected with influenza virus 2 days previously.
(B) Recipient mice were sacrificed 18–24 hr after transfer, and BAL, lung parenchyma, PBL, and spleen were harvested, and the ratio of Sendai NP324-332K
b+ cells
from the input populations was assessed by flow cytometry in each tissue. The ratio of Sendai NP324-332K
b+ cells in the input population was determined by stain-
ing an aliquot of mixed cells prior to injection.
(C) Splenocytes from Sendai-immune C57BL/6 or congenic (CD90.1+) wild-type mice were harvested as previously described, except that B6 splenocytes were
incubated in 100 mg/ml Met-RANTES prior to mixing with CD90.1+ splenocytes for i.v. transfer.
(D) The ratio of control (CD90.1+) or Met-RANTES-treated (B6) Sendai NP324-332K
b+ cells was calculated for each tissue as described above. The data are shown
as the mean ± SD of five individual mice and are representative of three independent experiments.when compared to wild-type cells in the same host (Figure 3A,
lower panel and Figure 3B, right panel), demonstrating that
CCR5 expression on memory T cells is required for inflamma-
tion-driven localization to the airways. Therefore, although
CXCR3 was abundantly expressed on the systemic memory
T cell population, these data suggested that CCR5 expression,
and not CXCR3 expression, was required during the early phase
of recruitment.
Although the data implicated a key role for CCR5, there are
several caveats associated with the dual-transfer approach.
Critically, the experimental approach required that the effect of
chemokine-receptor deficiency was assessed on secondary
rather than primary memory T cells. Therefore, to confirm our
findings from the secondary-memory model, we tested the abil-
ity of primary memory T cells to traffic to various tissues by using
a competitive in vivo recruitment assay. Total memory CD8+
T cells from Sendai-immune wild-type and CCR5-deficient
mice were harvested 2 days after virus challenge, and equal
numbers of antigen-specific cells from each donor were injected
into congenic recipients (Figure 4A). As shown in Figure 4B, the
1:1 ratio of wild-type to CCR5-deficient Sendai memory donor
cells was maintained in the lung parenchyma, peripheral blood,
and spleen 18 hr after transfer. However, the ratio of wild-type106 Immunity 29, 101–113, July 18, 2008 ª2008 Elsevier Inc.to CCR5-deficient cells was highly skewed in the lung airways,
where approximately 90% of the Sendai NP324-332K
b+ cells
were from the wild-type donor (CD90.1+). This result not only
confirmed the data obtained by the secondary-memory ap-
proach, but also clearly illustrated that the CCR5-mediated
recruitment of memory T cells was specific for the lung airways
and not the lung parenchyma, suggesting that different mecha-
nisms are responsible for directing migration to distinct compart-
ments within the lung.
We considered the possibility that these data were influenced
by differences in the memory CD8+ T cell populations between
wild-type and CCR5-deficient mice. However, there was no
abnormal distribution of memory CD8+ T cell subsets between
wild-type and CCR5-deficient mice, nor were there differences
in the expression of adhesion molecules known to be important
for retention of memory T cells in the lung (Ray et al., 2004)
(Figure S3). Nevertheless, it is possible that subtle differences
existed between the populations as a result of initial priming in
a wild-type versus CCR5-deficient environment. To control for
this, we performed a similar in vivo recruitment assay with
wild-type cells that were left untreated or treated with the
CCR5 antagonist Met-RANTES prior to transfer (Figure 4C). As
shown in Figure 4D, the ratio of control to Met-RANTES-treated
Immunity
Memory CD8+ T Cell Recruitment to the Lung AirwaysFigure 5. CCR5 Is Rapidly Expressed on the Surface of Memory CD8+ T Cells after Virus Challenge
C57BL/6 mice were infected i.n. with 250 EID50 Sendai virus and allowed to rest for 45 days.
(A) Splenocytes were harvested from Sendai-immune mice prior to or on days 1–5 post-challenge with x31 influenza virus, and the expression of CCR5 on
antigen-specific memory CD8+ T cells was analyzed by flow cytometry. Representative CCR5 staining gated on Sendai NP324-332K
b+ cells is shown for days
0–3 after challenge.
(B) Cumulative data from several experiments were graphed as the frequency of CCR5+ cells among total Sendai NP324-332K
b+ cells. Each symbol represents an
individual mouse, and the data are combined from three independent experiments.
(C) Splenocytes were harvested from resting Sendai memory mice (filled squares) or Sendai memory mice 2 days after challenge with x31 influenza (open
squares). Purified CD8+ T cells from each population were tested for their ability to migrate in vitro to increasing concentrations of CCL3. The data are displayed
as the chemotactic index (mean ± SD) of Sendai NP324-332K
b+ cells from each population and are representative of three independent experiments.
(D) Sendai-specific memory CD8+ T cells were analyzed for surface and intracellular expression of CCR5. Representative surface, intracellular, and isotype stain-
ing is shown gated on CD8+ Sendai NP324-332K
b+ cells.
(E) The frequency of surface or intracellular CCR5+ cells among Sendai NP324-332K
b+ splenocytes was graphed for several resting Sendai memory mice. The lines
shown connect the surface and intracellular results for individual mice.
(F) The frequency of resident (CD11alo) or recently recruited (CD11ahi) Sendai NP324-332K
b+ cells in the airways positive for internal CCR5 expression in resting
memory mice (left panel) or on day 3 after challenge (right panel) was measured by flow cytometry. Each symbol represents an individual mouse.
The data from (D)–(F) are representative of three independent experiments.cells was again highly skewed in the lung airways, but not the
lung parenchyma, peripheral blood, or spleen. Therefore, to-
gether with Figure 3, these data conclusively demonstrated
that CCR5 expression on memory CD8+ T cells plays a key
role in their accelerated recruitment to the lung airways during
the early stages of a recall response.
Memory CD8+ T Cells Rapidly Increase Surface
Expression of CCR5 after Virus Challenge
The finding that the early recruitment of memory CD8+ T cells is
CCR5 dependent was surprising in light of the observation that
only a small fraction of virus-specific memory T cells generated
after respiratory infections express CCR5. To investigate this
apparent disparity, we examined the expression of CCR5 onSendai-specific memory CD8+ T cells in the secondary lymphoid
organs after virus challenge. As shown in Figures 5A and 5B, the
frequency of memory T cells that expressed CCR5 was signifi-
cantly increased (p = 0.001) by 1 day after infection compared
to memory T cells from resting mice and peaked by day 2,
when approximately 10% of all Sendai-specific CD8+ T cells in
the spleen expressed CCR5. The increased frequency of
CCR5+ cells was a transient event, however, because by day 3
after infection there was no difference in CCR5 expression com-
pared to resting memory mice. Notably, the increased expres-
sion of CCR5 had a functional impact on migratory ability,
because memory CD8+ T cells isolated 2 days after challenge
could migrate in response to CCR5 ligands ex vivo, whereas
cells from resting memory mice could not (Figure 5C).Immunity 29, 101–113, July 18, 2008 ª2008 Elsevier Inc. 107
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face expression is that pre-existing CCR5 protein stored within
intracellular compartments was localized to the cell surface in re-
sponse to inflammation, similar to the process that had been pre-
viously described for the expression of CXCR1 on CD8+ T cells
(Gasser et al., 2005). As shown in Figures 5D and 5E, the fre-
quency of resting antigen-specific memory CD8+ T cells that
expressed intracellular CCR5 protein was significantly higher
(p < 0.0001) than the frequency of cells that expressed CCR5
on the cell surface. On average, the frequency of cells that
expressed intracellular CCR5 was five times greater than those
that expressed CCR5 on the surface (10% compared to 2%, re-
spectively, Figure 5E). Therefore, although we cannot exclude
the possibility of enhanced CCR5 gene expression, the rapid
and transient increase in CCR5 surface expression on memory
CD8+ T cells as a result of inflammation may be partially depen-
dent upon the presence of intracellular stores of CCR5 protein.
The finding that early memory T cell recruitment to the lung air-
ways was mediated by CCR5 implied that the cells recently re-
cruited during virus challenge (i.e., CD11ahi) would uniformly
express CCR5. Surprisingly, we found that very few recently re-
cruited Sendai-specific memory T cells in the lung airways ex-
pressed CCR5 on the cell surface after virus challenge (data
not shown). However, a widely recognized outcome of the inter-
action between chemokine receptors and their ligands is that,
after chemokine binding, engaged receptors are internalized
(Thomas et al., 2007). Thus, in accordance with our previous
findings, we expected that a high frequency of the cells recently
recruited to the airways during inflammation would contain intra-
cellular CCR5 protein. As shown in Figure 5F, in resting memory
mice (control, left panel), the frequency of both resident
(CD11alo) and recently recruited (CD11ahi) Sendai NP324-332K
b+
cells containing intracellular CCR5 was relatively low, and there
were no differences between the two populations. In contrast,
on day 2 after challenge (right panel), coinciding with the onset
of accelerated memory T cell recruitment, the majority of recently
recruited (CD11ahi) Sendai NP324-332K
b+ cells contained intracel-
lular CCR5. Collectively, these results demonstrate that CCR5 is
rapidly expressed on memory CD8+ T cells after virus challenge,
rendering these cells capable of migrating in response to CCR5
ligands, which is necessary for the accelerated recruitment of
memory T cells to the lung airways in response to inflammation.
CCR5-Dependent Recruitment Is Required
for the Expression of Antiviral Molecules
by Memory T Cells in the Airways
Having established a role for CCR5 in the accelerated early re-
cruitment of memory CD8+ T cells to the lung airways, we sought
to examine whether a lack of accelerated early recruitment im-
pacts the functional attributes of the memory T cell population
in the airways during the early stages of a virus challenge. There-
fore, we generated mixed bone-marrow chimeras to allow us to
compare the effector functions of both wild-type and CCR5-de-
ficient memory T cell populations in the lung airways of the same
animal. In resting Sendai memory chimeras, equal numbers of
wild-type and CCR5-deficient Sendai-specific memory CD8+
T cells were detected in all tissues, and neither population
expressed granzyme B as measured by intracellular staining
(Figure 6A and data not shown). As observed previously, after108 Immunity 29, 101–113, July 18, 2008 ª2008 Elsevier Inc.heterologous challenge there was a significant increase (p =
0.001) in recently recruited (CD11ahi) wild-type, but not CCR5-
deficient, memory T cells to the lung airways (Figures 6B and
6C). Furthermore, only wild-type memory T cells showed in-
creased expression of granzyme B in the lung airways by day 3
after challenge, and this increase was observed only in the re-
cently recruited (CD11ahi) population (Figures 6B and 6D).
Importantly, similar frequencies of wild-type and CCR5-deficient
T cells expressed granzyme B in the lung tissue and spleen, sug-
gesting that the lack of granzyme B expression by CCR5-defi-
cient cells in the lung airways was due to the lack of accelerated
recruitment of these cells from the circulation. We observed no
difference in granzyme B expression between wild-type and
CCR5-deficient T cells at the peak of the acute response,
when recruitment to the airways is comparable, supporting the
idea that granzyme B expression is regulated prior to the locali-
zation of T cells to the lung airways (Figure S4).
We also investigated the production of IFN-g by memory
T cells in vivo by injecting mice with brefeldin A and performing
intracellular cytokine staining immediately after harvest. As
shown in Figures 6E and 6F, a significant increase (p = 0.03) in
the frequency of IFN-g+ cells was observed for wild-type but
not CCR5-deficient populations in the lung airways. Also, similar
to granzyme B, the expression of IFN-gwas restricted to recently
recruited (CD11ahi) cells. The inability of CCR5-deficient memory
T cells to produce IFN-gwas not an intrinsic defect, however, be-
cause both wild-type and CCR5-deficient splenocytes could
produce IFN-g in response to in vitro peptide stimulation
(Figure S5). Taken together, these data illustrate an important re-
lationship between accelerated early recruitment to the lung air-
ways and the capacity of memory CD8+ T cells within the lung
airways to deliver key antiviral effector functions.
CCR5-Dependent Recruitment of Memory T Cells Is
Necessary for Limiting Early Virus Replication during
Secondary Challenge
The data thus far demonstrate that CCR5 is a key mediator in
early memory CD8+ T cell recruitment to the lung airways, sug-
gesting that the absence of CCR5 expression would have a det-
rimental effect on viral control during the early phase of a recall
response. To test this idea, we compared the ability of wild-
type and CCR5-deficient mice to control a secondary influenza
virus infection (Figure S6A). Both wild-type and CCR5-deficient
mice showed similar virus titers after a primary infection with in-
fluenza x31, and had cleared virus by day 10 after infection
(Figure S6B). At day 2 after challenge with influenza PR8, prior
to the onset of accelerated memory T cell recruitment to the
lung airways, there was no difference in influenza virus titers be-
tween wild-type and CCR5-deficient mice (Figure 7). This result
was in agreement with the observation that resting memory wild-
type and CCR5-deficient mice had comparable numbers of
antigen-specific CD8+ T cells in the lung airways and lung paren-
chyma (Figure S3). However, by day 4 after infection, there was
a significant decrease (p = 0.05) in influenza virus titers in primed
wild-type mice compared to primed CCR5-deficient mice. The
ability of CCR5-deficient mice to effectively control virus replica-
tion at day 2 after infection, but not at day 4 after infection, sup-
ports the idea that early memory CD8+ T cell recruitment to the
lung airways during the initial days of a recall response serves
Immunity
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for the Expression of Antiviral Effector Molecules
by Memory CD8+ T Cells in the Lung Airways
Mixed bone-marrow chimeras were generated from wild-
type congenic and CCR5-deficient mice, infected with 250
EID50 Sendai virus, and rested for 45 days. Sendai-im-
mune chimeras were harvested at this time (control) or
after influenza virus challenge (day 3).
(A and B) Representative staining for CD11a and gran-
zyme B by wild-type (CD45.1+) and CCR5-deficient
Sendai NP324-332K
b+ cells in the airways is shown for (A)
resting memory mice or (B) on day 3 after influenza virus
challenge.
(C) The frequency of CD11ahi cells in the airways among
wild-type and CCR5-deficient Sendai NP324-332K
b+ cells
is graphed as the mean ± SD for resting control memory
mice or on day 3 after challenge.
(D) The frequency of granzyme B+ cells among Sendai
NP324-332K
b+ wild-type or CCR5-deficient cells in the air-
ways of resting memory mice (BAL, control), or in the
airways (BAL, day 3), lung parenchyma (lung), and spleen
on day 3 after challenge is graphed as the mean ± SD.
(E) The in vivo production of IFN-g by Sendai-specific
memory CD8+ T cells after virus challenge was measured
by direct intracellular cytokine staining (ICCS), and repre-
sentative staining of IFN-g and CD11a from Sendai
NP324-332K
b+ wild-type (left panel) or CCR5-deficient (right
panel) cells in the lung airways is shown.
(F) The frequency of IFN-g+ cells amongSendaiNP324-332K
b+
wild-type or CCR5-deficient cells in the lung airways from
resting control memory mice or on day 3 after challenge
is graphed as the mean ± SD for three individual mice. All
data for mixed bone-marrow chimeras representative of
three independent experiments.to limit early virus replication. In addition, although both wild-type
and CCR5-deficient mice were able to clear the secondary-chal-
lenge virus by day 8, clearance was more rapid in wild-type mice
(67% of wild-type had cleared virus by day 6 after challenge
compared to 17% of CCR5-deficient mice, data not shown).
The differences in virus titers had only a minimal impact on im-
munopathology in the lung, however, because both wild-type
and CCR5-deficient mice showed similar levels of inflammation
during the recall response (Figure S7). Importantly, we observed
no differences in virus titers between wild-type and CCR5-defi-
cient naive mice, suggesting that the differences in virus titers
observed between primed mice was due to the lack of acceler-
ated memory T cell recruitment in CCR5-deficient mice and
not to defects in innate immunity. These data demonstrate
a direct correlation between the ability of memory CD8+ T cells
to localize to the lung airways during the early stages of a recall
response in a CCR5-dependent manner and the ability of mem-
ory T cells to decrease virus burden at the site of infection prior to
the onset of a secondary effector response.
DISCUSSION
The early stages of a recall response to respiratory virus infec-
tions are characterized by the rapid recruitment of nonproliferat-ing memory T cells from the circulation to the lung. However, the
mechanisms that regulate this rapid response had not been
identified. Here we show that the chemokine receptor CCR5
plays a unique and nonredundant role in the early recruitment
of antigen-specific memory CD8+ T cells to the lung airways dur-
ing respiratory virus infections. This recruitment is driven by
localized inflammation, rendering memory T cells responsive to
CCR5-mediated migration and enabling the localization of mem-
ory T cells from the circulation to the airways. Importantly, the in-
hibition of CCR5-mediated recruitment impaired the control of
early virus replication prior to the onset of secondary effector T
cell responses.
CCR5 had been previously shown to be important for the mi-
gration of effector T cells to the interstitial spaces of the lung un-
der noninflammatory conditions, probably because of the con-
stitutive expression of CCL5 in lung tissue (Constantin et al.,
2000). It is important to note that our results differ in that CCR5
expression on memory CD8+ T cells is required for accelerated
recruitment to the lung airways, but not to the lung parenchyma,
during early stages of a respiratory infection. Also, the effect of
CCR5 on memory T cell recruitment to the airways is evident
only during times of increased inflammation, because the main-
tenance of memory T cells in the airways by steady-state recruit-
ment was not altered in CCR5-deficient or mixed bone-marrowImmunity 29, 101–113, July 18, 2008 ª2008 Elsevier Inc. 109
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that CCR5 plays a very specific role in directing the recruitment
of circulating Tem cells to the lung airways in response to a respi-
ratory virus challenge.
A critical aspect of our findings is that elimination of the early
phase of memory T cell recruitment resulted in a decrease in
the efficacy of viral control during a recall response. Our data
support the observation of Liang et al. (1994) that the efficacy
of early protection is linked to the presence of antigen-specific
CD8+ T cells in the lung. Protection observed at day 2 irrespec-
tive of CCR5 expression is in accordance with this observation,
because there were equal numbers of antigen-specific CD8+ T
cells in the lung airways of wild-type and CCR5-deficient mice
prior to the early recruitment of memory T cells from the circula-
tion. However, by day 4 after challenge, CCR5-deficient mice
had significantly higher viral titers (p = 0.05) than their wild-
type counterparts. These data suggest a revised model for early
cell-mediated protection from respiratory virus challenge; al-
though memory T cells present in the lung at the time of virus
challenge can serve to limit initial virus replication, the CCR5-de-
pendent recruitment of circulating memory T cells to the lung air-
ways is essential for the continued control of virus replication
Figure 7. Defective Memory CD8+ T Cell Recruitment to the Lung
Airways in CCR5-Deficient Mice Correlates with Increased Virus
Titers during Secondary Challenge
C57BL/6 and CCR5-deficient mice were primed with 500 EID50 x31 influenza
virus and allowed to rest for 45 days. Naive and x31-immune age-matched
mice were challenged with 6000 EID50 PR8, and whole lung tissue was har-
vested on the indicated days after challenge. Lung virus titers were measured
by plaque assay on days 2 (upper graph) and 4 (lower graph) after PR8 chal-
lenge. The data are graphed as the number of influenza PFUs per lung
(mean ± SD) for five individual mice per time point. The data are representative
of three independent experiments.110 Immunity 29, 101–113, July 18, 2008 ª2008 Elsevier Inc.prior to the arrival of secondary effector T cells in the lungs.
Because the systemic population of antigen-specific memory T
cells gradually converts from Tem to Tcm cells over time, there
is a gradual loss in the Tem cell population that coincides with
a decline of the early recall response and protective efficacy
(Liang et al., 1994). Similarly, the loss of the early phase of the re-
call response in CCR5-deficient mice results in impaired control
of early virus replication that closely resembles the declining ef-
ficacy of the recall response over time reported by Liang et al.
(1994). This model has important implications for the formulation
of vaccines designed to promote cellular immunity to respiratory
infections. Although many current vaccination strategies are de-
signed to promote the generation of antigen-specific Tcm cells
that in turn lead to an acceleration of the secondary effector
T cell response, optimal cell-mediated protection will also re-
quire the generation of circulating Tem cells capable of being
rapidly recruited to the lung airways.
The mechanisms by which by pathogen-specific T cells limit
virus replication in the lung include both the lysis of infected ep-
ithelial cells and the localized production of antiviral cytokines
(La Gruta et al., 2007). Through the use of mixed bone-marrow
chimeras, we observed that the expression of effector molecules
such as granzyme B and IFN-g by memory CD8+ T cells was lim-
ited to those cells that had been recently recruited (CD11ahi) to
the lung airways. Although these observations were made in
the absence of antigen stimulation, suggesting that inflammation
alone is sufficient to induce production of these antiviral media-
tors, we cannot formally rule out the possibility that a small fre-
quency of Sendai-specific T cells are capable of crossreacting
with influenza antigens. Nevertheless, the increased frequency
of granzyme B+ memory T cells after virus challenge was similar
between wild-type and CCR5-deficient memory CD8+ T cells in
the lung parenchyma and spleen, but significantly lower (p =
0.01) among CCR5-deficient cells in the lung airways at day 3
after challenge. Thus, the data support a model where memory
T cells are activated by inflammatory signals at other peripheral
and secondary lymphoid sites prior to their recruitment to the
lung airways.
The mechanisms responsible for the inflammation-dependent
expression of effector molecules in memory T cells and for the
increased surface expression of CCR5 after respiratory virus
challenge at sites distant from the infection are unclear but prob-
ably involve the early production of innate cytokines. For exam-
ple, it has been shown in other experimental systems that type I
interferons, IL-12, and IL-18 can result in the production of IFN-g
by memory T cells (Denton et al., 2007; Kamath et al., 2005; Raue
et al., 2004). In the case of respiratory viruses, infection of the
respiratory tract leads to the rapid induction of type I interferons
by dendritic cells, epithelial cells, and alveolar macrophages
(Cella et al., 2000; Kumagai et al., 2007). Furthermore, signaling
through the type I interferon receptor has been shown to provide
activation signals for effector and memory T cells (Alsharifi et al.,
2005; Sun et al., 1998). It has also been demonstrated that IL-12
can increase expression of CCR5 on memory T cells and alter the
homing pattern of these cells in vivo (Iwasaki et al., 2001; Mukai
et al., 2001). A thorough understanding of the role that early
innate cytokines play in these processes is essential for the ratio-
nal design of future cell-mediated vaccines, and we are continu-
ing to explore these questions.
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diating memory T cell recruitment after respiratory virus chal-
lenge, it is intriguing to envision a broader role for this process
during other inflammatory situations in the lung. Recent experi-
mental evidence has suggested a role for CCR5 in the pathogen-
esis of several pulmonary-disease models. For example, the
expression of CCR5 by CD8+ T cells in the lungs of COPD
patients, and the production of CCR5 ligands, correlated with
disease severity (Freeman et al., 2007). Furthermore, blocking
CCR5 interactions has been shown to inhibit allergen-induced
inflammation and airway remodeling, although a definitive role
for CD8+ T cells in these outcomes was not investigated
(Chvatchko et al., 2003; Ma et al., 2006). Several studies have
shown that the presence of pre-existing memory T cells capable
of being recruited to the lung airways can dramatically influence
the initiation and exacerbation of these pathologies (Curtis et al.,
2007; Marsland et al., 2004; Schaller et al., 2005). Thus, our cur-
rent findings suggest a potential role for CCR5-dependent mem-
ory CD8+ T cell recruitment in the onset and progression of these
pulmonary diseases.
In conclusion, we have shown that the accelerated recruitment
of antigen-specific memory CD8+ T cells to the lung airways dur-
ing respiratory virus challenge and the control of early virus rep-
lication are dependent on the expression of CCR5. Together,
these data identify the mechanism required for the initiation of
the early phase of memory CD8+ T cell recruitment during a recall
response to respiratory virus challenge, and they demonstrate
the key role that memory CD8+ T cells recruited early after virus
challenge play during the initial stages of cellular immunity in the
lung.
EXPERIMENTAL PROCEDURES
Viruses, Mice, and Infection
Sendai virus (Enders strain), influenza virus A/HK-x31 (x31, H3N2), and influ-
enza virus A/PR/8 (PR8, H1N1) were grown, stored, and titered as previously
described (Daly et al., 1995; Hou et al., 1992). C57BL/6, B6.SJL-Ptprca Pep3/
BoyJ (CD45.1), B6.Pl-Thy1a/Cy (CD90.1), and B6.Ccr5 / mice (Ccr5tm1Kuz)
(Sato et al., 1999) were purchased from The Jackson Laboratory (Bar Harbor,
ME). B6.Cxcr3/ mice have been previously described (Hancock et al.,
2000). Mice (8–12 wk old) were anesthetized by intraperitoneal injection of
2,2,2-tribromoethanol (200 mg/kg) and infected intranasally (i.n.) with 250
50% egg infectious doses (EID50) of Sendai virus or 500 EID50 influenza x31.
For virus-challenge experiments, Sendai- or Flu-immune mice were chal-
lenged with 3 3 104 EID50 influenza x31 or 6 3 10
3 EID50 influenza PR8,
respectively. All animal studies were approved by the Trudeau Institute Insti-
tutional Animal Care and Use Committee.
Tissue Harvest and Flow Cytometry
Mice were sacrificed at the indicated times and single-cell suspensions were
obtained from broncho-alveolar lavage (BAL), lung parenchyma, mediastinal
lymph node (MLN), peripheral blood, and spleen as previously described
(Hogan et al., 2002). Live-cell counts were determined by trypan-blue exclu-
sion. Isolated cells were incubated with Fc-block for 15 min on ice and then
stained with PE- or APC-labeled tetramers specific for the Sendai virus nucle-
oprotein epitope (Sen-NP324-332K
b) (Kast et al., 1991) or influenza nucleopro-
tein epitope (Flu-NP366-374D
b) (Townsend et al., 1986) for 1 hr at room temper-
ature. All MHC class I-peptide tetramers were generated by the Trudeau
Institute Molecular Biology Core. Tetramer-labeled cells were washed and
stained with Alexa405-, Pacific Blue-, Pacific Orange-, FITC-, Alexa488-,
PE-, PerCP-, PE-Cy7-, APC-, or APC-Alexa750-conjugated antibodies for
30 min on ice. In some instances, cells were then fixed and permeablized
with the Cytofix Cytoperm kit (BD Biosciences) to detect intracellular proteins.Antibodies were purchased from BD Biosciences (CD8, CD11a, CD27, CD43
[1B11], CD45.1, CD45.2, CD49a, CD62L, CD90.1, CD90.2, CD127, CCR5, and
IFN-g), Bio Legend (CD45.1, CD45.2, and CCR5), eBioscienes (CD8, CD44,
and CD45.2), Caltag Laboratories (CD8 and granzyme B), R&D Systems
(CXCR3), or Southern Biotech (KLRG1). Samples were run on either a FACSCa-
libur cytometer (BD Biosciences) or a CyAn ADP (Dako). All data were analyzed
with FlowJo software (Tree Star).
Direct In Vivo ICCS
Measurement of IFN-g producing cells in vivo was performed as previously
described, with minor alterations (Liu and Whitton, 2005). In brief, 6 hr prior
to harvest, mice were injected intravenously (i.v.) with 500 ml of a PBS solution
containing 0.5 mg/ml Brefeldin A (BFA, Sigma-Aldrich). Lung airway cells were
harvested by lavage (BAL) in ice-cold HBSS containing BFA. BAL cells were
stained with tetramers and antibodies to surface molecules as described
above expect that all steps were performed in the presence of BFA, and tetra-
mer staining was limited to 20 min at room temperature. Detection of intracel-
lular IFN-g was carried out after surface-marker staining and fixation as de-
scribed above.
Dual-Adoptive-Transfer and Mixed Bone-Marrow Chimera Models
Dual-adoptive-transfer experiments were performed as previously described
(Hikono et al., 2007). In brief, CD8+CD44hi splenocytes from congenic donors
were sorted on a FACSVantage with Diva option (BD Biosciences), the purified
populations were mixed so that the number of Sen-NP324-332K
b-specific T cells
were equal, and this mixture was then transferred i.v. into congenic recipients.
In some experiments, sorted CD8+CD44hi splenocytes from one congenic do-
nor were incubated with 100 mg/ml Met-RANTES (R&D Systems) for 2 hr at
37C. Cells were washed three times to remove unbound Met-RANTES prior
to mixing with cells incubated in media alone for i.v. transfer. For short-term
recruitment experiments, congenic recipient mice were sacrificed 18–24 hr af-
ter transfer. For the establishment of stable memory T cells derived from the
donor populations, naive recipients were infected with 250 EID50 Sendai virus
1 day after transfer and allowed to recover for 45 days prior to virus challenge.
Mixed bone-marrow chimeras were generated by following established proto-
cols (Mayer et al., 2008). Chimeras were rested for 6 weeks to allow for recon-
stitution, and all mice were bled to confirm the presence of the congenic donor
T cell populations prior to virus infection.
Real Time RT-PCR
Total RNA was extracted from lung homogenates with the Rneasy kit
(QIAGEN) and treated with DNA-free buffer (Ambion) according to the manu-
facturer’s instructions. Single-strand cDNA was synthesized with SuperScript
II reverse transcriptase (Invitrogen) and random primers. Primer and probe
sets for GAPDH, TNF-a, IFN-g, IL-1b, IL-6, CCL2, CCL3, CCL4, CCL5,
CCL11, CCL17, CCL20, CCL21, CCL22, CCL25, CCL28, CXCL2, CXCL9,
CXCL10, CXCL11, and CXCL16 were synthesized by the Trudeau Institute Mo-
lecular Biology Core Facility or purchased from Applied Biosystems. Real-time
RT-PCR was performed by the Taqman method with an Applied Biosystems
7700 sequence-detection system in 25 ml reactions (23 Taqman MasterMix,
0.75 ml/reaction of each primer and probe, and nuclease-free water in addition
to 5 ul of cDNA). Aliquots of cDNA equivalent to 10 ng/ml were used for real-
time PCR. The expression levels of mRNA were normalized to the median ex-
pression of a housekeeping gene (GAPDH). The data shown are presented as
the n-fold induction of the indicated gene on days 1–5 after heterologous virus
challenge relative to the expression of the indicated gene from resting memory
mice, and the results are graphed as the mean ± standard deviation (SD) for
three mice per time point.
Chemotaxis Assay
Chemotactic activity was determined with a standard migration assay as pre-
viously described (Partida-Sanchez et al., 2004). In brief, the indicated concen-
trations of the chemokines CCL3, CCL4, CCL5, CXCL9, CXCL10, or CXCL11
(Peprotech) were added to the bottom of the chamber of 24-well Transwell
chamber plates (5.0 mm pore size; Corning Costar) and incubated for 10 min,
at 37C, in 10% CO2. The transwell insert was then placed above the chamber,
and splenocytes (1 3 106) were then added to the transwell and incubated
for 2 hr at 37C, in 10% CO2. In some cases, CD8
+ T cells purified by negativeImmunity 29, 101–113, July 18, 2008 ª2008 Elsevier Inc. 111
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increase the number of antigen-specific T cells in the input population. After
incubation, 600 ml was removed from the bottom of the chamber and trans-
ferred to an Eppendorf tube. Cells were resuspended in 100 ml of FACS buffer
and stained for analysis as described above. Just prior to analysis, 5 3 104
polystyrene microspheres (Bangs Laboratories) were added to each sample
and used to calculate the total number of cells. The chemotactic index was cal-
culated as the number of cells migrating in response to the indicated chemokine
divided by the number of cells migrating in response to media alone (mean ± SD
for triplicate wells).
Measurement of Virus Titers
Whole lung tissue was harvested in PBS at the indicated times, and lung ho-
mogenates were made as previously described and stored at 70C (Crowe
et al., 2005). Virus titers were measured with a standard plaque assay by in-
fecting MDCK cell monolayers with serial 10-fold dilutions of lung suspension
in duplicate. Twenty-four hours after infection, monolayers were extensively
washed and fixed with 80% acetone in water. Infected cell clusters were de-
tected with a biotin-labeled mouse anti-influenza A monoclonal antibody
(Chemicon), followed by staining with streptavidin-AP, and visualized with
Sigma Fast BCIP/NBT substrate (Sigma). The number of plaque-forming units
(PFUs) was counted, and the data were shown as the PFU/lung (mean ± SD).
Statistical Analysis
Statistical analysis was performed with Prism GraphPad software. A two-tailed
Student’s t test was used to determine significance (p values) where indicated.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and
seven figures and can be found with this article online at http://www.
immunity.com/cgi/content/full/29/1/101/DC1/.
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